Today: August 31, 2015, 10:54 am

Belgium pharmaceuticals market: $7.85bn industry in 2013
Belgium Pharmaceuticals and Healthcare Report Q3 2013 - a new market research report on 2014-04-24 08:39:02
We continue to expect a year-on-year (y-o-y) contraction in the value of the Belgian pharmaceutical market in 2013, as public expenditure continues to be challenged by the need for cost containment. While high per capita consumption of medicines continue to offer opportunities for researchbased pharmaceutical companies, risks will remain elevated, especially given the current economic backdrop.

Headline Expenditure Projections

- Pharmaceuticals: EUR5.96bn (US$7.57bn) in 2012 to EUR5.85bn (US$7.85bn) in 2013; -1.80% in local currency terms and +3.6% in US dollar terms. Local currency forecast virtually unchanged from Q213.

- Healthcare: EUR40.37bn (US$51.26bn) in 2012 to EUR41.20bn (US$55.21bn) in 2013; +2.1% in local currency terms and +7.7% in US dollar terms. Local currency forecast broadly unchanged from Q213.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.